← Eichor
Condition: Inherited Abnormalities Of Platelets Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Inherited Abnormalities Of Platelets

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Endothelial Colony-Forming Cells in Patients With VWD, AVWS and Healthy Subjects
Phase N/A · 1 location(s) · Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico · NCT07358013Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)
Phase 1/Phase 2 · 25 location(s) · Vega Therapeutics, Inc · NCT05776069Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Phase 1 · 77 location(s) · Chugai Pharmaceutical · NCT06371417Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders
Phase 2/Phase 3 · 1 location(s) · Genesis Athens Clinic · NCT03937661Impact of Thrombocytopenia and Platelet Transfusions on Neonatal Bleeding and Inflammation
Phase N/A · 2 location(s) · Boston Children's Hospital · NCT03848923A Study of Bleeding and Treatment in Participants With Von Willebrand Disease
Phase N/A · 17 location(s) · Hemab ApS · NCT06610201Effect of MitoQ on Platelet Function and Reactive Oxygen Species Generation in Patients With Sickle Cell Anemia
NA · 5 location(s) · University of Pittsburgh · NCT04109820An Observational Study of Vonicog Alfa (rVWF) in Pediatric Participants With Von Willebrand Disease (vWD)
Phase N/A · 1 location(s) · Takeda · NCT07404644Efficacy and Safety of BT200 (Rondaptivon Pegol) in Patients With Type 2B Von Willebrand Disease
Phase 2 · 1 location(s) · Medical University of Vienna · NCT07273721Algorithm-based Management to Reduce the Recurrence of GI Bleeding and Severe Epistaxis in Von Willebrand Disease
NA · 17 location(s) · University Hospital, Lille · NCT06651255Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases
NA · 1 location(s) · University Hospital, Lille · NCT04119908Registry of Older Patients With Cancer
Phase N/A · 7 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137825Eptacog Beta in Glanzmann's (HeT_LFB-Strength-Study_FID531)
Phase 2 · 1 location(s) · Emory University · NCT07136857Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation
Phase N/A · 1 location(s) · Institut National de la Santé Et de la Recherche Médicale, F · NCT04902807Study to Evaluate Subcutaneous (SC) VGA039 in Patients With Von Willebrand Disease (VWD)
Phase 3 · 14 location(s) · Vega Therapeutics, Inc · NCT07115004National Longitudinal Cohort of Hematological Diseases
Phase N/A · 1 location(s) · Institute of Hematology & Blood Diseases Hospital, China · NCT04645199Study of Chediak-Higashi Syndrome
Phase N/A · 1 location(s) · National Human Genome Research Institute (NHGRI) · NCT00005917A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · 21 location(s) · Takeda · NCT05582993A Study of Recombinant Von Willebrand Factor (rVWF) in Chinese Participants With Von Willebrand Disease (vWD)
Phase 3 · 7 location(s) · Takeda · NCT071293433'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer
Phase N/A · 1 location(s) · Barbara Ann Karmanos Cancer Institute · NCT00935090A Pilot Crossover Trial of Prophylactic Wilate Compared to Placebo for Heavy Menstrual Bleeding in Patients with VWD
Phase 3 · 1 location(s) · Unity Health Toronto · NCT06205095Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford
Phase N/A · 2 location(s) · Sanford Health · NCT01793168Von Willebrand Factor in Pregnancy (VIP) Study
Phase N/A · 11 location(s) · University of Washington · NCT04146376Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders
Phase 2/Phase 3 · 1 location(s) · Genesis Athens Clinic · NCT05181748A Study Assessing HMB-002 in Participants With Von Willebrand Disease
Phase 1/Phase 2 · 25 location(s) · Hemab ApS · NCT06754852National Registry of Rare Kidney Diseases
Phase N/A · 1 location(s) · UK Kidney Association · NCT06065852Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Phase N/A · 1 location(s) · UNC Lineberger Comprehensive Cancer Center · NCT01137643ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.